Suppressive effect of global DNA hypomethylation on gastric carcinogenesis

Carcinogenesis
Hiroyuki TomitaAkira Hara

Abstract

Global DNA hypomethylation and concomitant site-specific gene hypermethylation are among the most common molecular alterations in human neoplasia. Although site-specific DNA hypermethylation has been shown to be associated with the development of various tumors accompanied by transcriptional silencing of target genes, the functional significance of global DNA hypomethylation in tumorigenesis remains unclear. Previous studies have revealed that a genetic reduction of the DNA methylation levels leads to opposing effects on tumor development, depending on the tumor cell type and the stage of tumorigenesis. In the present study, we investigated the effect of DNA hypomethylation on gastric carcinogenesis in mice. The genetic reduction of DNA methylation levels suppressed the incidence, number and size of gastric tumors in two different mouse models for gastric tumorigenesis: the N-methyl-N-nitrosourea-induced model and the Apc(Min/+) mouse model that spontaneously develops gastric tumors with aging. Histological analyses revealed DNA hypomethylation to completely inhibit the development of invasive gastric tumors. These findings indicate that the reduction of DNA methylation levels suppresses gastric carcinogenesis and suggest that ...Continue Reading

References

Mar 26, 1984·Nucleic Acids Research·J SanfordN Hastie
Apr 21, 1995·Cell·P W LairdR Jaenisch
Sep 17, 1998·Nature·R Z ChenR Jaenisch
Sep 25, 1999·International Journal of Cancer. Journal International Du Cancer·H SuzukiK Imai
Apr 6, 2000·Journal of the National Cancer Institute·G TamuraS J Meltzer
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Feb 4, 2003·American Journal of Human Genetics·S L SlagerS N Thibodeau
Mar 4, 2003·Gastroenterology·Gregory P BoivinRobert J Coffey
Apr 19, 2003·Science·Amir EdenRudolf Jaenisch
Apr 19, 2003·Science·François GaudetRudolf Jaenisch
May 15, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Gyeong Hoon KangHwoon-Yong Jung
Mar 5, 2004·Cancer Cell·Toshikazu Ushijima, Mitsuru Sasako
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ki Taek NamDae-Yong Kim
Sep 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Yasuhiro YamadaRudolf Jaenisch
Feb 10, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Takao MaekitaToshikazu Ushijima
Nov 23, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Takeshi NakajimaDaizo Saito
Mar 31, 2007·Journal of Biochemistry and Molecular Biology·Toshikazu Ushijima

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.